GlassScriptPhysician profile
Aditya D Bulusu
NPI 1982697074
$6,047.76
in general payments reported to CMS, 2019-2025
37 companies · $2,449 in 2025
The $2,449 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $152 · 2021: $668 · 2022: $444 · 2023: $1,281 · 2024: $869 · 2025: $2,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698 · Travel and Lodging: $1,713 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,697.85 |
| Travel and Lodging | $1,713.31 |
| Education | $188.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,663.75 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $782.36 | 2025 | |
| Medtronic, INC. | $430.49 | 2021-2025 | Interstim |
| Calyxo, INC. | $366.49 | 2021-2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $338.15 | 2021-2025 | Lynparza |
| Janssen Biotech, INC. | $326.90 | 2024-2025 | Erleada, Akeega, Balversa |
| Medtronic USA, INC. | $278.64 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $180.30 | 2024-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $175.00 | 2019-2025 | Xtandi |
| Merck Sharp & Dohme LLC | $164.25 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $118.83 | 2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $115.97 | 2024-2025 | Prolaris |
| Novartis Pharmaceuticals Corporation | $109.20 | 2024-2025 | |
| Olympus America INC. | $104.33 | 2019-2025 | Itind System |
| Coloplast Corp | $83.18 | 2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $78.83 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.66 | 2024-2025 | |
| Urovant Sciences INC | $67.00 | 2022 | |
| Urogen Pharma, INC. | $61.97 | 2025 | |
| Verity Pharmaceuticals INC. | $50.41 | 2025 | Trelstar |
| Sight Sciences, INC. | $44.80 | 2025 | Omni Surgical System |
| Tolmar, INC. | $40.42 | 2025 | Eligard, Jatenzo |
| Accord Healthcare, INC. | $37.29 | 2025 | |
| Endo USA, INC. | $36.17 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $36.01 | 2024-2025 | Stravix Pl, Stravix |
| Palette Life Sciences, INC. | $34.66 | 2022 | |
| Janssen Scientific Affairs, LLC | $31.27 | 2024 | Pipeline, Erleada |
| Avyxa Pharma, LLC | $28.38 | 2025 | |
| Organon LLC | $26.67 | 2025 | |
| Dendreon Pharmaceuticals LLC | $24.33 | 2024 | Provenge |
| Abbvie INC. | $23.20 | 2025 | |
| Photocure INC | $21.72 | 2025 | Cysview |
| Valencia Technologies Corporation | $21.71 | 2025 | Ecoin Device Kit |
| Antares Pharma, INC. | $19.94 | 2024 | Xyosted |
| Laborie Medical Technologies Corp. | $16.75 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bioprotect Medical, INC. | $15.73 | 2025 | Bioprotect Balloon Implant System |
| Alnylam Pharmaceuticals INC. | $14.00 | 2025 | Oxlumo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Bulusu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.